Research Article: Meta-analyses of the association of G6PC2 allele variants with elevated fasting glucose and type 2 diabetes

Date Published: July 13, 2017

Publisher: Public Library of Science

Author(s): Yuanyuan Shi, Yuqian Li, Jinjin Wang, Chongjian Wang, Jingjing Fan, Jingzhi Zhao, Lei Yin, Xuejiao Liu, Dongdong Zhang, Linlin Li, Zhongxue Chen.


To collectively evaluate the association of glucose-6-phosphatase catalytic unit 2 (G6PC2) allele variants with elevated fasting glucose (FG) and type 2 diabetes (T2D).


PubMed, Web of Knowledge and Embase databases.

Full text articles of studies that identified an association of G6PC2 with T2D and elevated FG.

There was no T2D patient involvement in the analyses on the association of FG with G6PC2, there were T2D patients and non-diabetes patient involvement in the analyses on the association of T2D with G6PC2.

Random-effects meta-analyses were used to calculate the pool effect sizes. I2 metric and H2 tests were used to calculate the heterogeneity. Begg’s funnel plot and Egger’s linear regression test were done to assess publication bias.

Of the 423 studies identified, 21 were eligible and included. Data on three loci (rs560887, rs16856187 and rs573225) were available. The G allele at rs560887 in three ethnicities, the C allele at rs16856187 and the A allele at rs573225 all had a positive association with elevated FG. Per increment of G allele at rs560887 and A allele at rs573225 resulted in a FG 0.070 mmol/l and 0.075 mmol/l higher (ß (95% CI) = 0.070 (0.060, 0.079), p = 4.635e-50 and 0.075 (0.065, 0.085), p = 5.856e-48, respectively). With regard to the relationship of rs16856187 and FG, an increase of 0.152 (95% CI: 0.034–0.270; p = 0.011) and 0.317 (95% CI: 0.193–0.442, p = 6.046e-07) was found in the standardized mean difference (SMD) of FG for the AC and CC genotypes, respectively, when compared with the AA reference genotype. However, the G-allele of rs560887 in Caucasians under the additive model and the C-allele of rs16856187 under the allele and dominant models were associated with a decreased risk of T2D (OR (95% CI) = 0.964 (0.947, 0.981), p = 0.570e-4; OR (95% CI) = 0.892 (0.832, 0.956), p = 0.001; and OR (95% CI) = 0.923(0.892, 0.955), p = 5.301e-6, respectively).

Our meta-analyses demonstrate that all three allele variants of G6PC2 (rs560887, rs16856187 and rs573225) are associated with elevated FG, with two variants (rs560887 in the Caucasians subgroup and rs16856187 under the allele and dominant model) being associated with T2D as well. Further studies utilizing larger sample sizes and different ethnic populations are needed to extend and confirm these findings.

Partial Text

Fasting plasma glucose (FPG) levels are associated with a risk of type 2 diabetes (T2D) and cardiovascular disease [1]. There is strong evidence suggesting that hyperglycemia is a risk factor in a dose-dependent manner for both micro- and macro-vascular complications in both type 1 and type 2 diabetes [2].

To the best of our knowledge, this is the most comprehensive meta-analyses on the evaluation of the associations between G6PC2 SNPs and FG and T2D. Our meta-analyses include the most SNPs in G6PC2 on the associations of these SNPs with FG and T2D studied to date. In these meta-analyses, we analyzed three SNPs (rs560887, rs16856187 and rs573225) in the G6PC2 gene for an effect on FG and two SNPs (rs560887 and rs16856187) for an association with T2D. We found that all three SNPs were associated with elevated FG level in participants with normal glucose regulation, and rs560887 in the Caucasians subgroup and rs16856187 under allele and dominant model were all associated with T2D.




0 0 vote
Article Rating
Notify of
Inline Feedbacks
View all comments